Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy
| Autor: | Nouraldeen Manasrah, Ali Al Sbihi, Dahlia Sano, Sarah Lonardo |
|---|---|
| Rok vydání: | 2023 |
| Předmět: |
Oncology
medicine.medical_specialty Lymphoma B-Cell medicine.medical_treatment Case Report Stage ii 03 medical and health sciences 0302 clinical medicine Chemoimmunotherapy hemic and lymphatic diseases Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Neoplasm Humans Stage (cooking) Chemotherapy business.industry Head and neck cancer Remission Induction Complete remission General Medicine medicine.disease Burkitt Lymphoma Lymphoma 030220 oncology & carcinogenesis Immunotherapy business 030215 immunology |
| Zdroj: | BMJ Case Rep |
| ISSN: | 1757-790X |
| Popis: | Burkitt lymphoma (BL) is a rare, mature, fast-growing and highly aggressive B-cell neoplasm. It has a high-proliferation rate with distinctive genetic changes in the C-MYC oncogene. Treatment usually requires intense and frequent chemotherapy regimens with central nervous system prophylaxis as the usual regimens used for other non-Hodgkin’s lymphoma yield poor survival in BL. This report discusses a patient who was diagnosed with a stage II, high-grade BL who received one cycle of intense chemotherapy and refused further treatment. That patient remained in complete remission in his last follow-up; 7 years from diagnosis without requiring other therapies for his lymphoma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|